Although si‐ Ripk3 @Exo exhibited an inhibitory trend on serum‐induced AD‐like pathologies (Figure S17A–D ), western blot analysis indicated that the reduction in p‐Tau levels did not reach statistical significance.
← all excerpts
Neuron-Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer's Disease.
1
—
—